Nanjing King-Friend Biochemical Pharma Registers Regadenoson Injection in China; Shares Up 3%
Nanjing King-Friend Biochemical Pharma Registers Regadenoson Injection in China; Shares Up 3%
南京证券生物化学药业在中国注册了雷加诺生注射液; 股价上涨3%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册